At the end of the latest market close, Biora Therapeutics Inc. (BIOR) was valued at $0.26. In that particular session, Stock kicked-off at the price of $0.27 while reaching the peak value of $0.27 and lowest value recorded on the day was $0.23. The stock current value is $0.23.Recently in News on November 14, 2022, Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results. Presented results of human study at the American College of Gastroenterology annual meeting, demonstrating promising device performance in active ulcerative colitis patients . You can read further details here
Biora Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3100 on 01/04/22, with the lowest value was $0.2200 for the same time period, recorded on 11/17/22.
Biora Therapeutics Inc. (BIOR) full year performance was -94.73%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Biora Therapeutics Inc. shares are logging -95.51% during the 52-week period from high price, and 6.68% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.22 and $5.23.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1792809 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Biora Therapeutics Inc. (BIOR) recorded performance in the market was -88.77%, having the revenues showcasing -72.83% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 38.58M, as it employees total of 124 workers.
Specialists analysis on Biora Therapeutics Inc. (BIOR)
During the last month, 0 analysts gave the Biora Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.5880, with a change in the price was noted -0.46. In a similar fashion, Biora Therapeutics Inc. posted a movement of -66.41% for the period of last 100 days, recording 1,683,405 in trading volumes.
Trends and Technical analysis: Biora Therapeutics Inc. (BIOR)
Raw Stochastic average of Biora Therapeutics Inc. in the period of last 50 days is set at 2.94%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.39%. In the last 20 days, the company’s Stochastic %K was 14.43% and its Stochastic %D was recorded 12.61%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -88.77%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -69.40%, alongside a downfall of -94.73% for the period of the last 12 months. The shares increased approximately by -12.13% in the 7-day charts and went up by -41.33% in the period of the last 30 days. Common stock shares were lifted by -72.83% during last recorded quarter.